pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Emsam
drug
save

selegiline ER

Marketedupdated 3mo ago
by Mylan Specialty LP
Approved
community read0 votes

indications

investigational
Major Depression

all catalysts(0)

nothing on the calendar yet

Trials studying selegiline ER

  • phase1A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjectsnot yet recruitingn=230
  • —Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjectscompletedn=12

News(0)

no news has mentioned this drug yet

brand
Emsam
generic
selegiline
indication
Major Depressive Disorder
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 28m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?